Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrine-Related Cancer

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1677/ERC-06-0075PMID 18045956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.

  2006cited by this paper
• In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

  2006cited by this paper
• Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer

  2005cited by this paper
• Serum Insulin-Like Growth Factor I Levels in Growth Hormone-Deficient Adults: Influence of Sex Steroids

  2005cited by this paper
• Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.

  2005cited by this paper
• Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families

  2005cited by this paper
• Sex Steroids and the Growth Hormone/Insulin-Like Growth Factor-I Axis in Adults

  2005cited by this paper
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

  2004cited by this paper
• The insulin-like growth factor system in advanced breast cancer.

  2004cited by this paper
• IGF-I in mammary tumorigenesis and diabetes.

  2004cited by this paper
• Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions

  2004cited by this paper
• Insulin-Like Growth Factor (IGF)-System mRNA Quantities in Normal and Tumor Breast Tissue of Women with Sporadic and Familial Breast Cancer Risk

  2004cited by this paper
• Insulin-Like Growth Factor and Breast Cancer Risk: Evidence from Observational Studies

  2003cited by this paper
• Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors.

  2003cited by this paper
• Functional and Physical Interactions between BRCA1 and p53 in Transcriptional Regulation of the IGF-IR Gene

  2003cited by this paper
• BRCA1–Sp1 interactions in transcriptional regulation of the IGF‐IR gene

  2003cited by this paper
• IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content.

  2002cited by this paper
• Insulin-like growth factors and breast cancer risk in Chinese women.

  2002cited by this paper
• Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention

  2001cited by this paper
• Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

  2001cited by this paper
• Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-α and interferon-γ

  2001cited by this paper
• Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation

  2001cited by this paper
• Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-alpha and interferon-gamma.

  2001cited by this paper
• A cross-sectional study of IGF-I determinants in women

  2001cited by this paper
• Local feedback mechanisms in human breast cancer

  2000cited by this paper
• Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.

  2000cited by this paper
• Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCAmutations

  2000cited by this paper
• Serum insulin‐like growth factor‐I and breast cancer

  2000cited by this paper
• Down‐regulation of insulin‐like growth factor‐I receptor and insulin receptor substrate‐1 expression in advanced human breast cancer

  2000cited by this paper
• Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer.

  2000cited by this paper
• Normal growth and development in the absence of hepatic insulin-like growth factor I.

  1999cited by this paper
• Insulin-Like Growth Factor I

  1999cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.

  1997cited by this paper
• The localization of the insulin‐like growth factor receptor 1 (IGFR‐1) in benign and malignant breast tissue

  1997cited by this paper
• The IGF-I receptor in cell growth, transformation and apoptosis.

  1997cited by this paper
• Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.

  1997cited by this paper
• BRCA1 mutations in young women with breast cancer.

  1996cited by this paper
• Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• 妊娠時における糖尿病網膜症とInsulin-like growth factor I(IGF-I)

  1994cited by this paper
• Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS).

  1993cited by this paper
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper
• Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer.

  1993cited by this paper
• of Insulin-Like Growth

  1993cited by this paper

• Complex Interplay Between Obesity and BRCA1/2‐Associated Breast Cancer: An Overview

  2025cites this paper
• The Role of Cow’s Milk Consumption in Breast Cancer Initiation and Progression

  2023cites this paper
• BRCA1: An Endocrine and Metabolic Regulator

  2022cites this paper
• IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.

  2020cites this paper
• Role of the GH-IGF1 system in progression of cancer.

  2020cites this paper
• Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer

  2019influential citation
• Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.

  2019cites this paper
• Identification of MΦ specific POTEE expression: Its role in mTORC2 activation via protein-protein interaction in TAMs.

  2019cites this paper
• Update on PARP Inhibitors in Breast Cancer

  2018cites this paper
• Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines

  2018cites this paper
• Comprehensive Proteomic Profiling–derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas

  2018cites this paper
• A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers

  2018cites this paper
• Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.

  2016cites this paper
• On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer

  2016influential citation
• Molecular basis of carcinogenesis in diabetic patients (review).

  2015cites this paper
• Klotho: a novel biomarker for cancer

  2015cites this paper
• Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

  2015cites this paper
• Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation

  2015cites this paper
• Insulin-Like Growth Factor and Epidermal Growth Factor Signaling in Breast Cancer Cell Growth: Focus on Endocrine Resistant Disease

  2015cites this paper
• Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort

  2015cites this paper
• BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer

  2014cites this paper
• A randomized controlled trial of diet and physical activity in BRCA mutation carriers

  2014cites this paper
• The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells

  2014cites this paper
• Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel

  2014cites this paper
• Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.

  2014cites this paper
• A Comprehensive Literature Analysis of Causes and Treatment Options for Hereditary Breast Cancer

  2013cites this paper
• The potential of hypoxia markers as target for breast molecular imaging – a systematic review and meta-analysis of human marker expression

  2013cites this paper
• Breast cancer risk in BRCA 1 mutation carriers : insight frommouse models

  2013cites this paper
• Breast cancer risk in BRCA1 mutation carriers: insight from mouse models.

  2013cites this paper
• BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype

  2012cites this paper
• BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site

  2012cites this paper
• The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers

  2012cites this paper
• IGF-1 and BRCA1 signalling pathways in familial cancer.

  2012cites this paper
• BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines

  2012cites this paper
• Abnormal Mammary Adipose Tissue Environment of Brca1 Mutant Mice Show a Persistent Deposition of Highly Vascularized Multilocular Adipocytes.

  2011cites this paper
• Gerosuppressant Metformin: less is more

  2011cites this paper
• Glucose Metabolism Disorders and the Risk of Cancer

  2011cites this paper
• Comparison of Radioimmuno and Carbon Nanotube Field-Effect Transistor Assays for Measuring Insulin-Like Growth Factor-1 in a Preclinical Model of Human Breast Cancer

  2011cites this paper
• Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy.

  2011cites this paper
• Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families

  2011cites this paper
• Insulin Resistance and Cancer: Epidemiology, Cellular and Molecular Mechanisms and Clinical Implications

  2011cites this paper
• IGF-I and Insulin Receptor Families in Cancer

  2011cites this paper
• The role of microRNAs in mammary tumorigenesis

  2011influential citation
• Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin

  2010cites this paper
• Molecular imaging of tumor characteristics to support targeted cancer therapies. A preclinical focus on HER2, HER3, c-Met, IGF-1R and VEGF-A imaging

  2010cites this paper
• BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.

  2009cites this paper
• Insulin‐like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma

  2009cites this paper
• Local Expression of Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer

  2009cites this paper
• Physical activity, obesity and risk for esophageal adenocarcinoma.

  2009cites this paper
• A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.

  2009cites this paper
• Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

  2009cites this paper
• IGF signaling pathway as a selective target of familial breast cancer therapy.

  2008cites this paper
• Reapprasial of the role of endocrine therapy in meningioma management.

  2008cites this paper
• IGF and Insulin Receptor Signaling in Breast Cancer

  2008cites this paper